0001127602-12-023455.txt : 20120801 0001127602-12-023455.hdr.sgml : 20120801 20120801193959 ACCESSION NUMBER: 0001127602-12-023455 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120731 FILED AS OF DATE: 20120801 DATE AS OF CHANGE: 20120801 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Dittrich Thomas J.W. CENTRAL INDEX KEY: 0001491654 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-12477 FILM NUMBER: 121001415 MAIL ADDRESS: STREET 1: AMGEN INC. STREET 2: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320-1799 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AMGEN INC CENTRAL INDEX KEY: 0000318154 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 953540776 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 BUSINESS PHONE: (805)447-1000 MAIL ADDRESS: STREET 1: ONE AMGEN CENTER DRIVE CITY: THOUSAND OAKS STATE: CA ZIP: 91320 FORMER COMPANY: FORMER CONFORMED NAME: AMGEN DATE OF NAME CHANGE: 19870305 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2012-07-31 0000318154 AMGEN INC AMGN 0001491654 Dittrich Thomas J.W. ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 1 VP, Finance & CAO Common Stock 2012-07-31 4 M 0 25000 69.83 A 38721 D Common Stock 2012-07-31 4 M 0 3000 42.13 A 41721 D Common Stock 2012-07-31 4 M 0 2000 50.44 A 43721 D Common Stock 2012-07-31 4 M 0 2150 58.43 A 45871 D Common Stock 2012-07-31 4 S 0 32150 82.687 D 13721 D Nqso (Right to Buy) 69.83 2012-07-31 4 M 0 25000 0 D 2007-05-15 2013-05-15 Common Stock 25000 0 D Nqso (Right to Buy) 42.13 2012-07-31 4 M 0 3000 0 D 2009-04-29 2015-04-29 Common Stock 3000 0 D Nqso (Right to Buy) 50.44 2012-07-31 4 M 0 2000 0 D 2010-04-28 2016-04-28 Common Stock 2000 2000 D Nqso (Right to Buy) 58.43 2012-07-31 4 M 0 2150 0 D 2011-04-26 2020-04-26 Common Stock 2150 4300 D The price reported is an average price. The prices ranged from $82.67 to $82.75 per share. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC, the issuer or a security holder of the issuer. The shares include the following Restricted Stock Units (RSUs) granted under the Company's equity plans: 286 RSUs which fully vest on 4/28/2013; 615 RSUs which vest in annual installments of 307 on 4/26/2013 and 308 on 4/26/2014; 1,714 RSUs which vest in annual installments of 565, 566 and 583 on 4/25/2013, 4/25/2014 and 4/25/2015, respectively; and 1,400 RSUs which vest in two equal installments of 462 each on 4/27/2014 and 4/27/2015 and one installment of 476 on 4/27/2016. Vested RSUs will be paid in shares of the Company's common stock on a one-to-one basis. These shares include 7 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited on the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount. /s/ Thomas J.W. Dittrich 2012-07-31